Axon degeneration in response to trophic deprivation was thought to be locally restricted to the axon. However, increasing evidence points to a requirement for the cell body in the degenerative program. Now, Simon et al. identify the pro-apoptotic protein Puma as a key factor in this cell body-derived signal.
In animal development, the immature nervous system grows an overabundance of axonal projections, the majority of which are pruned back by competition for limited target-derived signals such as neurotrophins. Axons that are outcompeted by their neighbors or fail to find their targets die back through a process known as axonal degeneration, which serves to optimize the nervous system and to ensure that only functional connections are maintained. Axon degeneration also happens in the mature nervous system in response to damage or disease, thus an understanding of the molecular mechanisms of this process has potential relevance for neural injury and neurodegenerative conditions. In the past few decades, great inroads have been made into the molecular mechanism of developmental axonal degeneration using the trophic deprivation paradigm, but it remained debatable whether this process was simply a local, axonal phenomenon or if it required signals from the cell body.
In this issue of Cell, Simon and colleagues provide convincing evidence that de novo transcription of proapoptotic protein Puma is required for axon degeneration in response to trophic deprivation (Simon et al., 2016) . The authors systematically examined the known players in this form of axon degeneration, essentially tracing incoming emergency signals from the axon back to the central Mission Control of the cell body, which then sends out a destruction command to the axon (Figure 1 ). Along the way, their data also resolve several previously conflicting observations about axon degeneration induced by trophic deprivation.
Prodigious effort has gone into teasing apart the signaling molecules involved in axon degeneration and so far the data point to somewhat parallel pathways at work (Pease and Segal, 2014) . Intriguingly, different pathways may be engaged depending on the nature of the insult; for example, pathways involved in developmental degeneration or pruning, tested with trophic deprivation in embryonic cultures, may not be the same pathways involved in response to trauma, such as axotomy (Luo and O'Leary, 2005) .
In the context of developmental axon degeneration, recent studies have established signaling roles for MAP kinases DLK and JNK, and caspases, although the role of the apoptotic machinery has been a point of debate (Cusack et al., 2013; Freeman, 2014; Pease and Segal, 2014) . Specifically, caspases and other proteolytic molecules are present within axons, and local trophic deprivation using compartmented cultures results in axon degeneration, so it was assumed that this is a local process not involving the cell body. However, detaching axons from the cell bodies before deprivation of trophic factors actually protects axons from degeneration (Gerdts et al., 2013) , suggesting that the cell body was somehow required, although whether it contributed actively through issuing a prodegeneration command or by passively providing components for the pathway remained unknown.
Using a variety of chemical inhibitors in combination with genetic manipulations, Simon and colleagues trace the pathway from axonal Akt signaling, downstream of the neurotrophin receptor TrkA, through disinhibition of both the transcription factor Foxo3a and the DLK/ JNK/c-Jun pathway, both of which lead to a crucial gating role of the cell body. It is worth noting that although a previous report using a Nestin-Cre conditional c-Jun knockout line concluded that c-Jun is not required for axon degeneration (Ghosh et al., 2011) , Simon and colleagues use a lentivirus-delivered Cre to more efficiently inhibit c-Jun expression, putting it firmly in the degeneration pathway.
Given that the apoptosis factor BAX was previously implicated in axon degeneration (Cusack et al., 2013; Nikolaev et al., 2009) , the authors next screen a panel of genetic mutants or knocked down pro-apoptotic BH3-only members of the Bcl-2 family and identified Puma as being required for axon degeneration and a target for transcription by Foxo3a. Puma is expressed at low levels basally, which increases with trophic deprivation, and genetic loss of Puma dramatically protects axons from degeneration (Simon et al., 2016) .
Puma, also known as BBC3, was originally identified as a target of the tumor suppressor p53 and binding partner of the anti-apoptosis protein Bcl-2 (Yu and Zhang, 2008) . Examining Puma localization in cultured embryonic sensory neurons, Simon and colleagues surprisingly find it is restricted to the cell body and not detectable by standard western blotting analysis of protein samples of axons separated from their cell bodies. Since previous studies investigating the axonal presence of various degeneration components using western blotting and immunostaining yielded conflicting results (Cusack et al., 2013; Nikolaev et al., 2009; Simon et al., 2012) , the authors turned to the more rigorous method of mass spectrometry analysis to probe for Puma peptides within isolated axon samples, which gave no evidence for Puma operating outside of the cell body.
Tellingly, removal or inhibition of Bcl-w and Bcl-xL, Puma's opponents in the apoptosis struggle, led to sensitization to axon degeneration. Indeed, without both Bcl proteins, neurons degenerate even in the presence of neurotrophin, an effect blocked by the genetic removal of Puma. However, even in the Puma/Bclw/Bcl-xL triple deletion condition there is still a small amount of axon degeneration (around 10%), which points to a minor contribution of a yet unknown signal acting in parallel with Puma to direct axon degeneration.
Some questions remain concerning how the destruction command from the cell body is relayed to the distant axon. The first and most obvious is what is the factor(s) downstream of Puma? Second, since Puma is restricted to the cell body, at what point along the chain of command does the destruction signal transition to the axon? While earlier studies raised questions about the roles of the mitochondrial factor cytochrome C and the downstream factor Apaf1 in axonal degeneration (Cusack et al., 2013; Pease and Segal, 2014) , Simon and colleagues have definitively shown here that Apaf1 is required for degeneration. Nonetheless, it remains to be addressed where precisely these factors lie between Puma and activated axonal caspases. Furthermore, in cases where only one segment of an axon, such as a branch, needs to be pruned, it is unknown how the destruction signal could be spatially restricted.
As with space missions, the cell body acts as mission control by issuing instructions to distant axons in response to the emergency signal of axonal trophic loss. In future studies, it will be interesting to see how developmental and pathological degeneration-such as when neurons are injured or in neurodegenerative diseases-overlap and diverge so as to aid in the development of specific and targeted therapies while sparing the overall organization and function of the healthy nervous system. Removal of nerve growth factor (NGF) from the culture medium leads to a decline in activity of its receptor, TrkA, which normally activates Akt. Loss of Akt signaling leads to the disinhibition of the transcription factor Foxo3a and of DLK, which activates JNK. Activated JNK travels to the cell body to activate c-Jun and together with Foxo3a leads to transcription of Puma. Elevated Puma levels overcome anti-apoptotic signaling of Bcl-w and Bcl-xL, leading to Bax activation, cytochrome C (cytC) ejection from mitochondria, with interacts with Apaf1, leading to activation of downstream caspases, resulting in axon degeneration.
